Sohm Financial Statements From 2010 to 2026
| SHMN Stock | USD 0.0009 0.00 0.00% |
Check Sohm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sohm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sohm financial statements analysis is a perfect complement when working with Sohm Valuation or Volatility modules.
Sohm |
Sohm Inc Company Return On Asset Analysis
Sohm's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Sohm Return On Asset | -0.25 |
Most of Sohm's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sohm Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Sohm Inc has a Return On Asset of -0.2478. This is 97.17% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 77.0% higher than that of the company.
Sohm Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sohm's current stock value. Our valuation model uses many indicators to compare Sohm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sohm competition to find correlations between indicators driving Sohm's intrinsic value. More Info.Sohm Inc is rated fifth in return on asset category among its peers. It is rated third in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sohm by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sohm's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Sohm Financial Statements
Sohm investors utilize fundamental indicators, such as revenue or net income, to predict how Sohm Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. SOHM, Inc. was founded in 2005 and is based in Corona, California. SOHM INC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 145 people.
Other Information on Investing in Sohm Pink Sheet
Sohm financial ratios help investors to determine whether Sohm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sohm with respect to the benefits of owning Sohm security.